PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Phenotype | C1704436|peripheral arterial disease |
| Sentences | 13 |
| PubMedID- 21145678 | peripheral arterial disease is a marker of systemic atherosclerosis and is associated with increased cardiovascular morbidity and mortality. |
| PubMedID- 22739422 | Angiographic score (asc) reflects severity of atherosclerosis in patients with peripheral arterial disease (pad). |
| PubMedID- 23233746 | Background: peripheral arterial disease is a manifestation of systemic atherosclerosis and is predictive of future cardiovascular events. |
| PubMedID- 22102786 | Altogether, further studies with other noninvasive modalities such as computed tomography and magnetic resonance imaging are recommended to determine the prevalence of carotid artery atherosclerosis in patients with peripheral arterial disease. |
| PubMedID- 23731050 | peripheral arterial disease due to atherosclerosis is known to be associated with a higher risk of myocardial infarction, stroke and all-cause mortality. |
| PubMedID- 26527957 | The balance between ros and no has played an important role in the development of atherosclerosis in patients with peripheral arterial disease. |
| PubMedID- 24489584 | Next, one of the organic diseases that causes peripheral hie is peripheral arterial disease due to arteriosclerosis [10]. |
| PubMedID- 25593383 | peripheral arterial disease, being a manifestation of systemic atherosclerosis, carries a high risk of adverse cardiovascular events. |
| PubMedID- 24067235 | peripheral arterial disease (pad), a manifestation of systemic atherosclerosis that produces blockages in arteries supplying the legs, affects an estimated 27 million people in europe and north america. |
| PubMedID- 21371639 | Objectives: the purpose of this analysis was to characterize the progression of coronary atherosclerosis in patients with concomitant peripheral arterial disease (pad). |
| PubMedID- 26044839 | Objective: the aim of this study was to evaluate the association of the calcification regulators, osteopontin (opn) and osteoprotegerin (opg),which are involved in vascular calcification and atherosclerosis in patients with peripheral arterial disease (pad). |
| PubMedID- 23803574 | Yet another study showed that elevated alp levels were associated with atherosclerosis, which leads to peripheral arterial disease and was assessed using the ankle-brachial blood pressure index, and that this association was independent of other traditional cardiovascular risk factors [29]. |
| PubMedID- 22884453 | Purpose: although risk factors for atherosclerosis in peripheral arterial disease (pad) are well defined, the underlying mechanisms are poorly understood and no medication exists for causal therapy. |
Page: 1